These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 37307220)
1. Comment on Parameswaran et al's "Increased Stroke Risk Following Herpes Zoster Infection and Protection With Zoster Vaccine". Lai SW Clin Infect Dis; 2023 Sep; 77(5):801-802. PubMed ID: 37307220 [No Abstract] [Full Text] [Related]
2. Increased Stroke Risk Following Herpes Zoster Infection and Protection With Zoster Vaccine. Parameswaran GI; Wattengel BA; Chua HC; Swiderek J; Fuchs T; Carter MT; Goode L; Doyle K; Mergenhagen KA Clin Infect Dis; 2023 Feb; 76(3):e1335-e1340. PubMed ID: 35796546 [TBL] [Abstract][Full Text] [Related]
3. Herpes zoster: epidemiology, natural history, and common complications. Weinberg JM J Am Acad Dermatol; 2007 Dec; 57(6 Suppl):S130-5. PubMed ID: 18021864 [TBL] [Abstract][Full Text] [Related]
4. Varicella and herpes zoster vaccines: WHO position paper, June 2014. Wkly Epidemiol Rec; 2014 Jun; 89(25):265-87. PubMed ID: 24983077 [No Abstract] [Full Text] [Related]
5. Herpes zoster vaccination: benefits and barriers. Komara FA J Am Osteopath Assoc; 2009 Jun; 109(6 Suppl 2):S22-4. PubMed ID: 19553633 [TBL] [Abstract][Full Text] [Related]
6. Editorial commentary: zoster vaccine in immunocompromised patients: time to reconsider current recommendations. Oxman MN; Schmader KE Clin Infect Dis; 2014 Oct; 59(7):920-2. PubMed ID: 25097080 [No Abstract] [Full Text] [Related]
7. Impact of influenza, herpes zoster, and pneumococcal vaccinations on the incidence of cardiovascular events in subjects aged over 65 years: a systematic review. Addario A; Célarier T; Bongue B; Barth N; Gavazzi G; Botelho-Nevers E Geroscience; 2023 Dec; 45(6):3419-3447. PubMed ID: 37269492 [TBL] [Abstract][Full Text] [Related]
8. Acute Cardiovascular Events after Herpes Zoster: A Self-Controlled Case Series Analysis in Vaccinated and Unvaccinated Older Residents of the United States. Minassian C; Thomas SL; Smeeth L; Douglas I; Brauer R; Langan SM PLoS Med; 2015 Dec; 12(12):e1001919. PubMed ID: 26671338 [TBL] [Abstract][Full Text] [Related]
9. Reducing the incidence and severity of herpes zoster and PHN with zoster vaccination. Gelb LD J Am Osteopath Assoc; 2009 Jun; 109(6 Suppl 2):S18-21. PubMed ID: 19553631 [TBL] [Abstract][Full Text] [Related]
10. [Does vaccination prevent postherpetic neuralgia?]. Krome S Dtsch Med Wochenschr; 2011 Jun; 136(23):1240. PubMed ID: 21630167 [No Abstract] [Full Text] [Related]
11. [Active immunoprophylaxis to reduce clinical impact of Herpes Zoster and its complications]. Marino MG; Bagnato B; Torella I; Franco E Ig Sanita Pubbl; 2009; 65(3):299-311. PubMed ID: 19629155 [TBL] [Abstract][Full Text] [Related]
12. Herpes zoster vaccine: a shot to maintain wellbeing. Michel JP Aging Clin Exp Res; 2015 Feb; 27(1):1-3. PubMed ID: 25585545 [No Abstract] [Full Text] [Related]
13. Herpes zoster vaccination in people aged 50-59 years. Li HT; Lu S; Liu JM Clin Infect Dis; 2012 Apr; 54(7):929-30. PubMed ID: 22291102 [No Abstract] [Full Text] [Related]
14. Vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia. Betts RF J Am Acad Dermatol; 2007 Dec; 57(6 Suppl):S143-7. PubMed ID: 18021866 [TBL] [Abstract][Full Text] [Related]
15. [Vaccination against herpes-zoster: a new strategy for post-herpetic neuralgia]. Gil de Miguel A An R Acad Nac Med (Madr); 2009; 126(1):57-66; discussion 67-72. PubMed ID: 20432659 [TBL] [Abstract][Full Text] [Related]